HPAPI Summit
June 19, 2018
Incorporating insights from Pfizer, Genentech, Vertex, Biogen and Boehringer Ingelheim, this unique conference will delve into the scale-up, containment, risk-assessment, and outsourcing hurdles that need to be overcome to ensure your HPAPI development is robust, safe and cost-effective.
Listen to Lonza’s very own Head of Commercial Development, Maurits Janssen, give a talk titled “Requirements for Fully-Integrated Service-Offerings in a HPAPI and Cytotoxic Environment” on June 21st at 9:30 AM.
Join your colleagues at this event to ensure you’re up to speed with the most innovative potent compound handling approaches, and to prepare yourself to overcome any challenge complex potent compounds can pose.
